The Current Treatment Landscape of Malignant Pleural Mesothelioma and Future Directions.

ABSTRACT: The incidence of malignant pleural mesothelioma is expected to increase globally. New treatment options for this malignancy are eagerly awaited to improve the survival and quality of life of patients. The present article highlights the results of recent advances in this field, analyzing data from several relevant trials. The heterogeneous tumor microenvironment and biology, together with the low mutational burden, pose a challenge for treating such tumors. So far, no single biomarker has been soundly correlated with targeted therapy development; thus, combination strategies are often required to improve outcomes. Locally applied vaccines, the expansion of genetically engineered immune cell populations such as T cells, the blockage of immune checkpoints that inhibit anti-tumorigenic respons

SUBMITTER: Bertin B 

PROVIDER: S-EPMC10741667 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature